Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/jth.15346 http://scihub22266oqcxt.onion/10.1111/jth.15346 33877735!8362082!33877735     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Thromb+Haemost 2021 ; 19 (7): 1819-1822 Nephropedia Template TP {{tp|p=33877735|t=2021. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) |pdf=|usr=}}{{33877735}} gab.com Text Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) JO: J Thromb Haemost http://www.kidney.de/pget.php?&tw=1&pmid=33877735 #FOAvip Cases of unusual thrombosis and thrombocytopenia after administration of the ChAdOx1 nCoV-19 vaccine (AstraZeneca) have been reported. The term vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) was coined to reflect this new phenomenon. In vitro experiments with VIPIT patient sera indicated that high-dose intravenous immunoglobulins (IVIG) competitively inhibit the platelet-activating properties of ChAdOx1 nCoV-19 vaccine induced antibodies. Here, we report a case of a 62-year-old woman who had received this vaccine and developed VIPIT. She visited the emergency ward because of petechiae and hematomas. In the laboratory work-up, thrombocytopenia, low fibrinogen, elevated D-dimer, and positivity in the platelet factor 4/heparin-enzyme-immunoassay were present. Signs and symptoms of thrombosis were absent. Upon immediate therapy with non-heparin anticoagulation, high-dose IVIG, and prednisolone, laboratory parameters steadily improved and the patient was discharged from hospital without thrombotic complications. We conclude that early initiation of VIPIT treatment results in a swift response without thrombotic complications. Twit Text FOAVip Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) ????J Thromb Haemost http://www.kidney.de/pget.php?&tw=1&pmid=33877735 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33877735 #FOAvip English Wikipedia <ref>{{Cite pmid|33877735}}</ref> Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) #MMPMID33877735 Thaler J; Ay C; Gleixner KV; Hauswirth AW; Cacioppo F; Grafeneder J; Quehenberger P; Pabinger I; Knobl P J Thromb Haemost 2021[Jul]; 19 (7): 1819-1822 PMID33877735show ga Cases of unusual thrombosis and thrombocytopenia after administration of the ChAdOx1 nCoV-19 vaccine (AstraZeneca) have been reported. The term vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) was coined to reflect this new phenomenon. In vitro experiments with VIPIT patient sera indicated that high-dose intravenous immunoglobulins (IVIG) competitively inhibit the platelet-activating properties of ChAdOx1 nCoV-19 vaccine induced antibodies. Here, we report a case of a 62-year-old woman who had received this vaccine and developed VIPIT. She visited the emergency ward because of petechiae and hematomas. In the laboratory work-up, thrombocytopenia, low fibrinogen, elevated D-dimer, and positivity in the platelet factor 4/heparin-enzyme-immunoassay were present. Signs and symptoms of thrombosis were absent. Upon immediate therapy with non-heparin anticoagulation, high-dose IVIG, and prednisolone, laboratory parameters steadily improved and the patient was discharged from hospital without thrombotic complications. We conclude that early initiation of VIPIT treatment results in a swift response without thrombotic complications. |*Purpura, Thrombocytopenic, Idiopathic/chemically induced/diagnosis/drug therapy[MESH] |*Thrombocytopenia/chemically induced/diagnosis/drug therapy[MESH] |*Vaccines[MESH] |COVID-19 Vaccines[MESH] |ChAdOx1 nCoV-19[MESH] |Female[MESH] |Heparin[MESH] |Humans[MESH] |Middle Aged[MESH]Successful treatment of vaccine-induced prothrombotic immune thrombocy(epmc).pdf DeepDyve Pubget Overpricing